Drug interactions are reported among people who take Tarceva and Pepcid together. This review analyzes the effectiveness and drug interactions between Tarceva and Pepcid. It is created by eHealthMe based on reports of 312 people who take the same drugs from FDA and social media, and is updated regularly.
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>
Tarceva has active ingredients of erlotinib hydrochloride. It is often used in malignant respiratory tract neoplasm. (latest outcomes from Tarceva 16,312 users)
Pepcid has active ingredients of famotidine. It is often used in gastrooesophageal reflux disease. (latest outcomes from Pepcid 24,529 users)
On Aug, 30, 2016
312 people who take Tarceva, Pepcid are studied.
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
I have been taking Tarceva for 5 weeks . Severe head pains started 4 weeks ago brought on by standing up from sitting position, walking etc. No pain when sat down or lying down. Has anyone experienced this? CT scan normal. Blood test normal
On eHealthMe, Tarceva (erlotinib hydrochloride) is often used to treat malignant respiratory tract neoplasm. Pepcid (famotidine) is often used to treat gastrooesophageal reflux disease. Find out below the conditions the drugs are used for and how effective they are.
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.